Centipeda minima is a Chinese herbal medicine used in the treatment of various diseases including cancer. An ethanol extract of the herb, its four fractions with different polarities, and two volatile oils prepared by steam distillation (SD) and supercritical fluid extraction (SFE) were investigated for their antiangiogenic activity in a wild-type zebrafish model using a quantitative endogenous alkaline phosphatase (EAP) assay. The SFE oil displayed potent antiangiogenic activity. Fifteen sesquiterpene lactones (SLs; compounds 1-15) isolated from the SFE oil were evaluated for their anti-angiogenic effect. Results revealed that pseudoguaianolide type SLs (1-8) inhibited vessel formation in the zebrafish embryos while guaianolide type SLs (9-15) showed little effect. Among the active ones, 6-O-angeloylenolin (1), a major component of SFE oil, possessed the strongest effect by reducing vessel formation in zebrafish embryos to 40% of the control value at 29.7 μM. Further study using the Tg (fli1a:EGFP) y1-type zebrafish model revealed that it blocked both intersegmental blood vessels (ISVs) and subintestinal vessels plexus (SIVs) formation in zebrafish embryos. Real-time polymerase chain reaction assay on the wild-type zebrafish embryos suggested that 6-O-angeloylenolin affected multiple molecular targets related to angiogenesis including VEGF receptor, angiopoietin, and its receptors. Taken together, our findings demonstrate that C. minima possesses anti-angiogenic activity, and 6-O-angeloylenolin is a promising candidate for the development of an anti-angiogenic agent.
Angiogenesis is the process by which new blood vessels develop from pre-existing vasculature. Persistent unregulated angiogenesis will cause angiogenic diseases including cancer [1] . For tumor growth and metastasis, angiogenesis increases the supply of nutrients, oxygen and growth factors to solid tumors and facilitates the removal of metabolic wastes from them [2] . It is believed that controlling tumor angiogenesis is one of the key issues in arresting tumor growth and metastasis. Therefore, anti-angiogenesis becomes an attractive therapeutic strategy in the treatment of cancer [2] . In recent years, anti-angiogenic drugs such as bevacizumab, sunitinib and sorafenib have been clinically used to treat colorectal cancer, breast cancer, non-small cell lung cancer and renal cell carcinoma [3] .
Centipeda minima (L.) A. Br. et Aschers (Compositae family) is a herb widely distributed in China and southeast Asian countries. It is traditionally used in Chinese folk medicine for treatment of nasal allergy, rhinitis, sinusitis, cough, headache and nasopharyngeal carcinoma (NPC) [4] . Pharmacological studies showed that C. minima possessed anti-cancer, anti-allergic, anti-protozoal, antibacterial, antioxidant and anti-inflammatory effects [5] . Sesquiterpene lactones (SLs) are the main bioactive constituents of this herb [6] , and their anti-cancer activities have been reported [5d, 6b, 6c]. 6-O-Angeloylenolin is the most important anti-cancer SLs in C. minima [6c-6e]. Besides in-vitro anti-cancer activities against both human promyelocytic leukemia (HL60) and human nasopharyngeal cancer cell lines (CNE) [6e], it has been reported to exhibit potent anti-multiple myeloma activity in nude mice and favorable pharmacokinetics in rats, and inhibit solid cancer growth in Lewis lung cancer xenograft models [6d, 6e]. Despite numerous reports on its anti-cancer activity, C. minima has not been reported for its anti-angiogenic activity. Thus, its extracts and isolated compounds were evaluated for their anti-angiogenic activity using the in vivo zebrafish model. Then the most active component was explored for its molecular mechanism.
Using endogenous alkaline phosphatase (EAP) staining, antiangiogenic activities among the extracts and their fractions from C. minima were revealed. In Figure 1A , the ethanol, n-hexane and ethyl acetate (EtOAc) fractions showed dose-dependent inhibition in vessel formation. For example, at a concentration of 45μg/mL, vessel formations were reduced to 85.4, 61.3, and 75.3% of the control value, respectively. However, neither n-butanol (BuOH) nor aqueous (Aq) fractions showed any significant effect at any concentration (p>0.05). Overall, the low polarity n-hexane fraction showed the strongest anti-angiogenic effect, and contained the active component. As this fraction contained several volatile constituents [5c], two alternative methods, namely, steam distillation (SD) and supercritical fluid extraction (SFE) were evaluated for their efficiency to recover them; the anti-angiogenic property of the two volatile oils was evaluated. In fact, both oils inhibited vessel formation in a dose-dependent manner ( Figure 1B ). For instance, at the concentration of 30 μg/mL for both SD and SFE oils, vessel formations were significantly reduced to 83.5 and 60.2% of the control value, respectively (p < 0.05). Not only did the SFE oil possess stronger effect than that of the SD oil, it also had a much better effect than that of the n-hexane fraction. For example, with the n-hexane fraction at 30 μg/mL, the vessel formation was merely reduced to 80.6% of the control value ( Figure 1A ). Apparently, SFE oil was more potent in anti-angiogenesis than the other extracts and fractions, and it was the most active extract of the herb. Anti-angiogenic activity of SD oil and SFE oil of C. minima. Effects were assessed by measuring the vessel formation of samples as compared with the control (0.2% DMSO was used as carrier control) using the quantitative EAP assay. SU5416, a known effective inhibitor of angiogenesis, was chosen to conduct the parallel experiments. Data are expressed as means ± standard deviation (n = 10). Data are expressed as means ± standard deviation (n = 10). Significant difference between sample and control is denoted with * (p < 0.05), ** (p < 0.01), and *** (p < 0.001) in one-way ANOVA followed by Dunnett's test. Fifteen sesquiterpene lactones (SLs) isolated from the SFE oil ( Figure 2 ) [6a, 6b] were tested for their anti-angiogenic effect. Different SLs with similar structures showed very different results ( Table 1 ). Among them, compound 1 (6-O-angeloylenolin) had the strongest anti-angiogenic effect. For example, after the embryos were treated with compound 1 at the concentration of 29.7 μM (10 μg/mL), vessel formation was significantly (p < 0.05) reduced to 60% of the control value. To reach the same percentage, the concentrations of compounds 2-8 would have to be in the range of 120-500 μM. For compounds 9-15, little anti-angiogenic effects were observed, even at a concentration higher than 500 μM. Compound 1 was the only SL with an anti-angiogenic effect stronger than that of the SFE oil ( Figure 1B ). Structurally, pseudoguaianolide type SLs (1-8) showed potent anti-angiogenic effect, but not the guaianolide types (9) (10) (11) (12) (13) (14) (15) .
To confirm further the anti-angiogenic effect of 6-O-angeloylenolin at the concentration of 30 μM, microscopic imaging on the Tg(fli1a:EGFP)y1-type zebrafish embryos was used. Both the intersegmental blood vessels (ISVs) and the subintestinal vessels plexus (SIVs) were the most conspicuous at 48 and 72 h postfertilization (hpf), respectively ( Figures 3A and 3B ). DMSO at 0.2% was the vehicle control based on its weak vessel inhibition. 6-O-Angeloylenolin partially blocked ISVs formation at 48 hpf after treatment for 24 h ( Figure 3A' ) and almost completely inhibited SIVs formation at 72 hpf after treatment for 48 h (Figure 3B '). As 6-O-angeloylenolin showed strong anti-angiogenic activity in the zebrafish model, its molecular mechanism was further studied in this model. Vascular endothelial growth factor (VEGF)/VEGF receptor 2 (KDR), and angiopoietin (Angpt)/Angpt receptors (Tie) are two important signaling pathways in angiogenesis [7] . The major angiogenic genes, including VEGF165, VEGF121, KDR, Angpt1, Angpt2, Angpt4, Tie1, and Tie2, which participate in the two pathways, were investigated. In Figure 4 , the mRNA expressions of KDR, Angpt1, Angpt2, and Tie2 were significantly the VEGF in the VEGF/KDR pathway. For the Angpt/Tie pathway, it significantly reduced the gene expressions of angiopoietin and its receptors. Overall, the anti-angiogenic effect was mainly mediated through blocking the formation of both ISVs and SIVs in the zebrafish embryos.
In angiogenesis, VEGF/KDR and Angpt/Tie are the two most important signaling pathways [7, 8] . VEGF is a potent angiogenic factor that mediates most biological functions via KDR. VEGF165 and VEGF121 are two predominant isoforms. KDR expression is restricted primarily to the vasculature and is the key mediator of VEGF-induced angiogenesis [7, 9] . The Angpt/Tie system acts as a vascular specific ligand/receptor system essential for blood vessel formation. The human Angpt family consists of two receptors (Tie1 and Tie2) and three ligands (Angpt1, Angpt2 and Angpt4). Angpt1 stimulates tumor growth by promoting endothelial cell survival and vessel maturation, but it inhibits tumor cell extravasation and maintains the integrity of healthy vessels outside tumors. Angpt4 is thought to act like Angpt1. Angpt2 is a more appealing therapeutic target because it mainly stimulates tumor growth. Angpt1 and Angpt2 are specific ligands of Tie2 with similar affinity, and Tie2 activation would promote vessel assembly and maturation. Tie1 is almost exclusively expressed by endothelial cells and critical for vascular development, but it is still largely considered as an orphan receptor [8] . So, co-blocking both VEGF/KDR and Angpt2/Tie2 signaling pathways are superior in inhibiting tumor angiogenesis, metastasis, and leakage. As 6-O-angeloylenolin interferes with both the VEGF/KDR and Angpt2/Tie2 signaling pathways, it is more effective to inhibit angiogenesis.
In conclusion, C. minima exhibits a potent anti-angiogenic property, and 6-O-angeloylenolin is targeted at both VEGF/KDR and Angpt/Tie signaling pathways. Overall, 6-O-angeloylenolin is a promising candidate for the development of an anti-angiogenic agent. Meanwhile, our findings may offer new insights for the application of C. minima in the treatment of cancer.
Experimental
Plant material: C. minima was collected in Baiyun Mountain, Guangzhou, China, and was authenticated by Mr Zhenqiu Mai, a senior herbalist at the Chinese Medicinal Material Company, Guangzhou, China. A voucher specimen (06115202) has been deposited in the Department of Biology, the Chinese University of Hong Kong.
Extractions, fractionation, isolation and structural identification:
The preparation of the ethanol extract of C. minima and its fractions was described previously [5c]. Briefly, the dried and cut herbs were extracted with 95% ethanol for 4 days. After filtration and concentration in vacuo, the extract was suspended in distilled water and partitioned successively with n-hexane, ethyl acetate (EtOAc) and n-butanol (BuOH). A residual aqueous (Aq) fraction remained. Solvent in each fraction was evaporated. Volatile oils of C. minima were obtained either by steam distillation (SD) or supercritical fluid extraction (SFE). Briefly, for SD, the herbs (300 g) were distilled using a Clevenger-type apparatus (800-7-B, Kimble Bomex, Beijing, China) for 5 h. For SFE, it (300 g) was extracted using supercritical extraction equipment (HA121-50-02, Jiangsu Nantong SFE Inc., Jiangsu, China), which contained a 2 L stainless steel vessel subjected to a pressure of 20 MPa at 40°C for 2 h. The flow rate of CO 2 was 20 L/h. The yield of SD and SFE oils were 0.13% and 5.0%, respectively. Fifteen SLs were isolated from the SFE oil using chromatographic methods, and their chemical structures were characterized by spectroscopic methods [6a, 6b] Embryo handling: Zebrafish of wild type (AB strain) and Tg (fli1a:EGFP) y1 type were used. The zebrafish were maintained at 28.5°C. The zebrafish embryos were generated by natural pairwise mating using the method of He et al. [10] , and were cultured in embryo water (0.2 g/L Instant Ocean Salt) at 28.5°C. After culture for 24 h, the embryos were manually dechorionated with forceps before drug treatments.
Quantitative EAP assay:
During zebrafish development, the stage between 24 and 72 hpf has the highest angiogenic activity The quantitative EAP assay (phosphatase substrate kit, Pierce, USA) was performed as described [9a]. Briefly, zebrafish (wild type) embryos (24 hpf) were arrayed in a 96-well plate (one embryo per well) and incubated with 100 μL of embryo water per well containing various concentrations of drugs. For control, only 100 μL embryo water was prepared. After incubation at 28.5°C for 48 h, the medium in each well was removed. The remaining embryos were first treated with 70% ethanol (100 μL) and subsequently with 100% ethanol (100 μL), both for dehydration purposes. The embryos were washed 3 times with diethanolamine buffer. Then, 100 μL stain solution was added to each well. The preparation of both diethanolamine buffer and stain solution were according to the manufacturer's instructions. After staining, 50 μL of 2M NaOH was added to stop the reaction, and then optical densities were determined at 405 nm. SU5416, a known inhibitory of angiogenesis, was chosen to conduct the parallel experiments [11] . All tests were run in triplicate. Vessel growth was presented as the percentage formation of vessels in optical density comparing with the control. 438 Natural Product Communications Vol. 11 (4) 2016
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Microscopic imaging on zebrafish embryo:
For better documentation of the development of the blood vessels, the embryos of the Tg (fli1a:EGFP) y1-type zebrafish were used because the vasculature of the green endothelial cells in both the ISVs at 48 hpf and SIVs at 72 hpf could be easily observed using a fluorescence microscope [12] . The embryos (24 hpf) were arrayed in a 96-well plate, and incubated with 100 μL of embryo water per well containing various concentrations of drugs. After further incubated for 24 h and 48 h, embryos were observed for their blood vessel development using an inverted microscope.
Total RNA isolation, reverse transcription and real-time polymerase chain reaction (RT-PCR):
Total RNA samples were extracted from the zebrafish embryos using Tri-Reagent (Molecular Research Center, Cincinnati, OH). Briefly, 20 embryos were lysed in 500 mL TRIzol Reagent. Chloroform (500 mL) was added to the TRIzol Reagent, mixed well, and kept at room temperature for 2 min. The mixture was centrifuged at 12,000 g for 15 min. The supernatant was transferred to a new tube and 500 mL isopropanol was added, mixed well, and stored at room temperature for 10 min. The RNA pellet was obtained by centrifugation at 12,000 g for 15 min. After washing the pellet with 70% ethanol, it was dissolved in DEPC water. Reverse transcription was performed in a total volume of 10 μL of reaction solution according to the Maloney murine leukemia virus (M-MLV) reverse transcriptase kit (Invitrogen, Carlsbad, CA). The expression levels of the tested genes and the internal control elongation factor 1 alpha (ef1a, housekeeping gene) in the embryos were examined by RT-PCR. The sequences of the primers are listed in Table 1 . The RT-PCR was performed on the CFX96 Real-Time PCR Detection System (Bio-Rad, Hong Kong) in a total volume of 10 μL containing 0.05 μL Takara Taq (5 units/μL), 0.5 μL EvaGreen (Biotum, Hong Kong) and 0.02 μL of each primer (10 μM). The reaction protocol was 42 cycles at 95°C for 20 s, 61°C for 20 s, and 72°C for 20 s.
The expression levels of the tested genes were normalized to that of ef1a and expressed as the fold change compared with the control group. All the experiments were performed in triplicate. 
